107 related articles for article (PubMed ID: 28646023)
41. Amlexanox Blocks the Interaction between S100A4 and Epidermal Growth Factor and Inhibits Cell Proliferation.
Cho CC; Chou RH; Yu C
PLoS One; 2016; 11(8):e0161663. PubMed ID: 27559743
[TBL] [Abstract][Full Text] [Related]
42. S100 calcium-binding protein A6 promotes epithelial-mesenchymal transition through β-catenin in pancreatic cancer cell line.
Chen X; Liu X; Lang H; Zhang S; Luo Y; Zhang J
PLoS One; 2015; 10(3):e0121319. PubMed ID: 25799022
[TBL] [Abstract][Full Text] [Related]
43. Updates in the biology and therapy for infant acute lymphoblastic leukemia.
Guest EM; Stam RW
Curr Opin Pediatr; 2017 Feb; 29(1):20-26. PubMed ID: 27841777
[TBL] [Abstract][Full Text] [Related]
44. Super elongation complex promotes early HIV transcription and its function is modulated by P-TEFb.
Kuzmina A; Krasnopolsky S; Taube R
Transcription; 2017 May; 8(3):133-149. PubMed ID: 28340332
[TBL] [Abstract][Full Text] [Related]
45. The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcome.
Külp M; Larghero P; Alten J; Cario G; Eckert C; Caye-Eude A; Cavé H; Schmachtel T; Bardini M; Cazzaniga G; De Lorenzo P; Valsecchi MG; Bonig H; Meyer C; Rieger MA; Marschalek R
Leukemia; 2023 Jun; 37(6):1216-1233. PubMed ID: 37100882
[TBL] [Abstract][Full Text] [Related]
46. Targeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Leonard JT; Rowley JS; Eide CA; Traer E; Hayes-Lattin B; Loriaux M; Spurgeon SE; Druker BJ; Tyner JW; Chang BH
Sci Transl Med; 2016 Aug; 8(354):354ra114. PubMed ID: 27582059
[TBL] [Abstract][Full Text] [Related]
47. Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemia.
Schneider P; Crump NT; Arentsen-Peters STCJM; Smith AL; Hagelaar R; Adriaanse FRS; Bos RS; de Jong A; Nierkens S; Koopmans B; Milne TA; Pieters R; Stam RW
Exp Hematol Oncol; 2023 Sep; 12(1):81. PubMed ID: 37740239
[TBL] [Abstract][Full Text] [Related]
48. Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia.
Sutton R; Shaw PJ; Venn NC; Law T; Dissanayake A; Kilo T; Haber M; Norris MD; Fraser C; Alvaro F; Revesz T; Trahair TN; Dalla-Pozza L; Marshall GM; O'Brien TA
Br J Haematol; 2015 Feb; 168(3):395-404. PubMed ID: 25312094
[TBL] [Abstract][Full Text] [Related]
49. N1-guanyl-1,7-diaminoheptane enhances the chemosensitivity of acute lymphoblastic leukemia cells to vincristine through inhibition of eif5a-2 activation.
Liu Y; Xue F; Zhang Y; Lei P; Wang Z; Zhu Z; Sun K
Anticancer Drugs; 2017 Nov; 28(10):1097-1105. PubMed ID: 28885268
[TBL] [Abstract][Full Text] [Related]
50. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
51. Upregulated expression of S100A6 in human gastric cancer.
Yang YQ; Zhang LJ; Dong H; Jiang CL; Zhu ZG; Wu JX; Wu YL; Han JS; Xiao HS; Gao HJ; Zhang QH
J Dig Dis; 2007 Nov; 8(4):186-93. PubMed ID: 17970874
[TBL] [Abstract][Full Text] [Related]
52. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
[TBL] [Abstract][Full Text] [Related]
53. Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene.
Elia L; Grammatico S; Paoloni F; Vignetti M; Rago A; Cenfra N; Mecarocci S; Mancini M; Luciani M; Di Raimondo F; Cazzaniga G; Matarazzo M; Moleti ML; Santoro L; Gaidano G; Foà R; Mandelli F; Cimino G
Am J Hematol; 2011 Dec; 86(12):993-7. PubMed ID: 21953510
[TBL] [Abstract][Full Text] [Related]
54. Leukemia propagating cells rebuild an evolving niche in response to therapy.
Duan CW; Shi J; Chen J; Wang B; Yu YH; Qin X; Zhou XC; Cai YJ; Li ZQ; Zhang F; Yin MZ; Tao Y; Mi JQ; Li LH; Enver T; Chen GQ; Hong DL
Cancer Cell; 2014 Jun; 25(6):778-93. PubMed ID: 24937459
[TBL] [Abstract][Full Text] [Related]
55. Acute Sensitivity of Ph-like Acute Lymphoblastic Leukemia to the SMAC-Mimetic Birinapant.
Richmond J; Robbins A; Evans K; Beck D; Kurmasheva RT; Billups CA; Carol H; Heatley S; Sutton R; Marshall GM; White D; Pimanda J; Houghton PJ; Smith MA; Lock RB
Cancer Res; 2016 Aug; 76(15):4579-91. PubMed ID: 27302164
[TBL] [Abstract][Full Text] [Related]
56. Were Ancestral Proteins Less Specific?
Wheeler LC; Harms MJ
Mol Biol Evol; 2021 May; 38(6):2227-2239. PubMed ID: 33528559
[TBL] [Abstract][Full Text] [Related]
57. S100A6 participates in initiation of autoimmune encephalitis and is under epigenetic control.
Lin CH; Li SC; Lin MH; Ho CJ; Lu YT; Lin Y; Lin PH; Tsai KW; Tsai MH
Brain Behav; 2023 Mar; 13(3):e2897. PubMed ID: 36748983
[TBL] [Abstract][Full Text] [Related]
58. Suppression of the NTS-CPS1 regulatory axis by AFF1 in lung adenocarcinoma cells.
Yue J; Dai Q; Hao S; Zhu S; Liu X; Tang Z; Li M; Fang H; Lin C; Luo Z
J Biol Chem; 2021; 296():100319. PubMed ID: 33493519
[TBL] [Abstract][Full Text] [Related]
59. The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia.
Külp M; Siemund AL; Larghero P; Dietz A; Alten J; Cario G; Eckert C; Caye-Eude A; Cavé H; Bardini M; Cazzaniga G; De Lorenzo P; Valsecchi MG; Diehl L; Bonig H; Meyer C; Marschalek R
iScience; 2022 Jul; 25(7):104613. PubMed ID: 35800767
[TBL] [Abstract][Full Text] [Related]
60. Neonatal congenital leukemia caused by several missense mutations and AFF1-KMT2A fusion: A case report.
Qin B; Dong X; Ding J
Oncol Lett; 2022 Aug; 24(2):283. PubMed ID: 35814831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
